
|Articles|June 1, 2004
- Volume 0 0
dual path
Advertisement
Articles in this issue
about 22 years ago
Examabout 22 years ago
Dual inhibition effective and safe in clinical practice: The EASE studyabout 22 years ago
Managed Care Commentary:MCOs face new challengesabout 22 years ago
Phytosterols may play role in atherosclerosisabout 22 years ago
Blocking intestinal cholesterol absorption for optimal lipid loweringabout 22 years ago
Dual pathway inhibition: Attacking cholesterol on two frontsabout 22 years ago
Future Goals, Targets, and Treatments of DyslipidemiaAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Novo Nordisk-Eli Lilly GLP-1 Ad Suit
2
FDA Approves Dolutegravirfor HIV Treatment in Newborns
3
FDA Clears First Continuous Glucose-Ketone Monitor
4
FDA Approves First-in-Class Daraxonrasib for Metastatic Pancreatic Cancer
5

































































































